A provider of data management services for clinical trials has purchased CardioNow from Agfa Healthcare.
Agfa sells CardioNow
A provider of data management services for clinical trials has purchased CardioNow from Agfa Healthcare. With this acquisition, BioClinica plans to add within 45 days the ability to track, share, blindly interpret, and archive medical images for multi-center clinical trials to its services portfolio. Neither the price of the acquisition nor other details regarding the acquisition were publicly released. Executives at BioClinica expect to integrate CardioNow services into their portfolio, extending the company’s ability to manage the process that begins after a medical image is acquired as part of a clinical trial. Imaging information will also be integrated with BioClinica Express electronic data capture to simplify and enhance the clinical trial process for life science companies, according to BioClinica.
Considering Breast- and Lesion-Level Assessments with Mammography AI: What New Research Reveals
June 27th 2025While there was a decline of AUC for mammography AI software from breast-level assessments to lesion-level evaluation, the authors of a new study, involving 1,200 women, found that AI offered over a seven percent higher AUC for lesion-level interpretation in comparison to unassisted expert readers.
SNMMI: Can 18F-Fluciclovine PET/CT Bolster Detection of PCa Recurrence in the Prostate Bed?
June 24th 2025In an ongoing prospective study of patients with biochemical recurrence of PCa and an initial negative PSMA PET/CT, preliminary findings revealed positive 18F-fluciclovine PET/CT scans in over 54 percent of the cohort, according to a recent poster presentation at the SNMMI conference.